Letter to the Editor: 1H, 15N, and 13C chemical shift assignments of the resuscitation promoting factor domain of Rv1009 from Mycobacterium tuberculosis by Cohen Gonsaud, M. et al.
 
 
Birkbeck ePrints: an open access repository of the 
research output of Birkbeck College 
 
http://eprints.bbk.ac.uk
 
 
Cohen-Gonsaud, Martin; Barthe, Philippe; Pommier, 
Françoise; Harris, Richard; Driscoll, Paul C.; Keep, 
Nicholas H. and Roumestand, Christian (2004). Letter to 
the Editor: 1H, 15N, and 13C chemical shift assignments 
of the resuscitation promoting factor domain of Rv1009 
from Mycobacterium tuberculosis. Journal of Biomolecular 
NMR 30 (3) 373 – 374. 
 
 
This is an author-produced version of a paper published in Journal of 
Biomolecular NMR (ISSN 0925-2738). This version has been peer-reviewed 
but does not include the final publisher proof corrections, published layout or 
pagination. All articles available through Birkbeck ePrints are protected by 
intellectual property law, including copyright law. Any use made of the 
contents should comply with the relevant law.  
Citation for this version: 
Cohen-Gonsaud, Martin; Barthe, Philippe; Pommier, Françoise; Harris, 
Richard; Driscoll, Paul C.; Keep, Nicholas H. and Roumestand, Christian 
(2004). Letter to the Editor: 1H, 15N, and 13C chemical shift assignments of 
the resuscitation promoting factor domain of Rv1009 from Mycobacterium 
tuberculosis. London: Birkbeck ePrints. Available at: 
http://eprints.bbk.ac.uk/archive/00000371
 
Citation for the publisher’s version:  
Cohen-Gonsaud, Martin; Barthe, Philippe; Pommier, Françoise; Harris, 
Richard; Driscoll, Paul C.; Keep, Nicholas H. and Roumestand, Christian 
(2004). Letter to the Editor: 1H, 15N, and 13C chemical shift assignments of 
the resuscitation promoting factor domain of Rv1009 from Mycobacterium 
tuberculosis. Journal of Biomolecular NMR 30 (3) 373 – 374. 
 
 
http://eprints.bbk.ac.uk
Contact Birkbeck ePrints at lib-eprints@bbk.ac.uk
 1
 
Letter to the Editor: 1H, 15N and 13C chemical shift assignments of the Resuscitation 
Promoting Factor domain of Rv1009 from Mycobacterium tuberculosis. 
 
Martin Cohen-Gonsaud a, Philippe Barthe b, Richard Harris c, Paul C. Driscoll c, Nicholas H. 
Keep a and Christian Roumestand b*. 
 
 
a School of Crystallography and Bloomsbury Centre for Structural Biology, Birbeck College, 
University of London, Malet Street, London, WC1E 7HX, UK  
 
b Centre de Biochimie Structurale, UMR 5048 CNRS/UM1 - UMR 554 INSERM/UM1, 
Faculté de Pharmacie, BP 14491, 15 Avenue Charles Flahault, 34093 Montpellier Cedex 5, 
France 
 
c Department of Biochemistry and Molecular Biology and Bloomsbury Centre for Structural 
Biology, University College London, Gower Street, London WC1E 6BT, UK 
 
*To whom correspondence should be addressed. 
Email address:  christian.roumestand@cbs.cnrs.fr 
 
Key words:  
Rpf, NMR assignments, Resuscitation promoting factors, Mycobacterium tuberculosis. 
 2
Biological context 
Studies of starved Micrococcus luteus have led to the identification of a secreted protein 
which resuscitates dormant cells allowing them to enter the cell cycle. This factor was named 
resuscitation promoting factor (Rpf) and has been classified as the first bacterial cytokine 
(Mukamolova, Kaprelyants et al. 1998). Homologues of the rpf genes are widely distributed 
among the high G+C cohort of Gram-positive bacteria including the mycobacterial pathogens 
M. tuberculosis and M. leprae (Mukamolova, Turapov et al. 2002).  M. tuberculosis can 
spend many years dormant in human tissue so the mechanism of revival of dormant M. 
tuberculosis is of major medical interest.  Genetic ablation of the unique rpf gene in M. luteus 
has been shown to be lethal (Mukamolova, Turapov et al. 2002), while in M. tuberculosis, 
which has five rpf genes, none of these genes was individually found to be essential 
suggesting functional redundancy (Tufariello, Jacobs et al. 2004). However, in a genome wide 
transposon mutagenesis study, the rpfB knockout exhibited a slow growth phenotype 
(Sassetti, Boyd et al. 2003). All five rpf homologues are expressed in M. tuberculosis in 
extended-stationary-phase cultures indicating a potential for Rpf to play a role in the 
reactivation of quiescent bacilli.  Recently, using sequence analysis and homology modelling, 
we predicted that the structure of the common sequence region of about 100 amino acids in 
the Rpf proteins possesses a lysozyme-like domain (Cohen-Gonsaud, Keep et al. 2004). Based 
on this analysis, we sub-cloned the core domain of rpfB (Rv1009). Here we report the 
expression, purification and the 1H, 15N and 13C resonance assignment of the corresponding 
protein called RpfBc. This work is the preliminary step toward obtaining the first atomic 
structure of a protein of the Rpf family, and an understanding of how the resuscitation 
promoting factors work particularly in M. tuberculosis. 
 
 
 
Methods and experiments 
Protein expression and Purification: The cDNA encoding for the 108 residues of RpfBc 
domain from M. tuberculosis was sub-cloned into a NdeI/BamHI site of an in-house 
engineered variant of pET15b (Novagen) that includes the replacement of the thrombin site 
coding sequence with a tobacco etch virus (TEV) protease site. The construct was 
transformed into Escherichia coli BL21-Rosetta (DE3) pLysS (Novagen) containing the 
pRARE plasmid (Novagen) to supply rare tRNA. Uniform 15N and 15N/13C labelling was 
obtained by growing cells (30 oC) in ECPM1 medium containing 15NH4Cl and 13C6 glucose as 
the sole nitrogen and carbon sources respectively. Protein expression was induced for 3 hours 
by addition of 0.5 mM IPTG. The cells were then harvested by centrifugation, and the pellet 
was sonicated in a lysis buffer (100 mM Tris/HCl pH 8.5, 5 mM β-mercaptoethanol). The 
supernatant was applied to a Ni-NTA column (Amersham Biosciences). After elution with 
imidazole and desalting into the TEV protease buffer (50 mM Tris-HCl pH 8.0, 0.5 mM 
EDTA, 10 mM DTT), the His6-fusion protein was cleaved overnight at 14 oC by addition of 
TEV protease. The cleaved protein was further purified using size exclusion chromatography 
with a Sephadex-HR75 column (Amersham Biosciences) equilibrated with the final sample 
buffer (25 mM Na-acetate pH 4.6, 2 mM β-mercaptoethanol) and finally concentrated to 
0.5 mM. 
NMR Spectroscopy: All NMR experiments were performed at 20 °C on a Bruker AVANCE 
500 MHz spectrometer equipped with a 5 mm Z-gradient 1H-13C-15N cryogenic probe. 1H 
chemical shifts were directly referenced to the methyl resonance of DSS, while 13C and 15N 
chemical shifts were indirectly referenced. The following spectra were used for the 1H, 15N, 
13Cα and 13Cβ and 13CO resonance assignments: 1H-15N-HSQC, HNCA, HN(CO)CA, HNCO, 
HN(CA)CO, HNCACB, CBCA(CO)NH essentially for sequential assignments, and 15N-
 3
edited HSQC-NOESY and HSQC-TOCSY experiments essentially for side chain 
assignments. All NMR experiments were processed with GIFA (Pons et al., 1996). 
 
Extent of assignments and data deposition 
The 1H-15N HSQC spectrum of RpfBc domain from M. tuberculosis is shown in Figure 1a. 
By combining the information from the heteronuclear experiments, we were able to assign 
98.5 % of the expected backbone resonances and 94.6 % of the side chain resonances. 
Residues from the C-terminal segment (Gly106-Arg108) and from the Pro18-Pro23 segment 
exhibit evidence for the presence of major and minor components. Potential sources for the 
minor peaks presumably involve local conformational exchange for the C-terminal segment, 
and proline isomerization for the Pro18-Pro23 segment. A 1H-15N heteronuclear NOE 
experiment was important for identifying the structured regions of the RpfBc construct. The 
1H-15N NOEs, shown in Figure 1b, indicate that the first 20 residues are very mobile. On the 
other hand, preliminary structures revealed that, consistent with previous proposals (Cohen-
Gonsaud, Keep et al. 2004), the core structure of RpfBc adopts roughly a lysozyme-like fold. 
The chemical shifts of the RpfBc domain of M. tuberculosis (major conformation) have been 
deposited in the BioMagResBank under the accession number BMRB-6221. A full 3D 
structure determination is in progress. 
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Figure legend 
Figure 1: (a) 1H-15N HSQC spectrum of RpfBc domain from M. tuberculosis recorded at 
20 oC. Negative peaks are shown in grey. The assignment of peaks is indicated with their one-
letter amino acid and number. Peaks belonging to a minor conformational component are 
indicated with an asterisk. (b) 1H-15N heteronuclear NOE ratios for RpfBc. 
 
 

